Reference:
Abd El-Aziz, T. M., & Stockand, J. D. (2020). Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.Infect Genet Evol, 83 (1567-7257 (Electronic)), 104327. doi: 10.1016/j.meegid.2020.104327
Amanat, F., & Krammer, F. (2020). SARS-CoV-2 Vaccines: Status Report. Immunity, 52 (4), 583-589. doi: 10.1016/j.immuni.2020.03.007
Arabi, Y. A.-O., Mandourah, Y., Al-Hameed, F., Sindi, A. A., Almekhlafi, G. A., Hussein, M. A., . . . Fowler, R. A. (2020). Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome. (1535-4970 (Electronic)).
Ashour, H. M., Elkhatib, W. F., Rahman, M., & Elshabrawy, H. A. (2020). Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks. Pathogens, 9 (3), 186.
Bernheim, A., Mei, X., Huang, M., Yang, Y., Fayad, Z. A., Zhang, N., . . . Chung, M. (2020). Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology, 295 (3), 200463. doi: 10.1148/radiol.2020200463
Bhimraj, A., Morgan, R. L., Shumaker, A. H., Lavergne, V., Baden, L., Cheng, V. C., . . . Falck-Ytter, Y. (2020). Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. LID - 10.1093/cid/ciaa478 [doi] LID - ciaa478. (1537-6591 (Electronic)).
Booth, C. M., Matukas Lm Fau - Tomlinson, G. A., Tomlinson Ga Fau - Rachlis, A. R., Rachlis Ar Fau - Rose, D. B., Rose Db Fau - Dwosh, H. A., Dwosh Ha Fau - Walmsley, S. L., . . . Detsky, A. S. (2020). Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. (0098-7484 (Print)).
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., . . . Wang, C. (2020). A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med, 382 (19), 1787-1799. doi: 10.1056/NEJMoa2001282
Chan-Yeung, M. (2004). Severe acute respiratory syndrome (SARS) and healthcare workers. Int J Occup Environ Health, 10 (4), 421-427. doi: 10.1179/oeh.2004.10.4.421
Chaolin, H., Yeming, W., Xingwang, L., Lili, R., Jianping, Z., Yi, H., . . . Bin, C. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet (Pre-publis).
Chaomin, W. (2020). Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.JAMA Internal Medicine .
Chappell, B. (2020). CORONAVIRUS: COVID-19 IS NOW OFFICIALLY A PANDEMIC.
Chen, H., Guo, J., Wang, C., Luo, F., Yu, X., Zhang, W., . . . Zhang, Y. (2020). Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.Lancet, 395 (10226), 809-815. doi: 10.1016/S0140-6736(20)30360-3
CHEN Jun, L. D., LIU Li, LIU Ping, XU Qingnian, XIA Lu, LING Yun, HUANG Dan, SONG Shuli, ZHANG Dandan, QIAN Zhiping, LI Tao, SHEN Yinzhong, LU Hongzhou. (2020). A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19).
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., . . . Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395 (10223), 507-513. doi: 10.1016/S0140-6736(20)30211-7
Cheng, Y., Wong R Fau - Soo, Y. O. Y., Soo Yo Fau - Wong, W. S., Wong Ws Fau - Lee, C. K., Lee Ck Fau - Ng, M. H. L., Ng Mh Fau - Chan, P., . . . Cheng, G. (2020). Use of convalescent plasma therapy in SARS patients in Hong Kong. (0934-9723 (Print)).
Chersich, M. F., Gray, G., Fairlie, L., Eichbaum, Q., Mayhew, S., Allwood, B., . . . Rees, H. (2020). COVID-19 in Africa: care and protection for frontline healthcare workers. Global Health, 16 (1), 46. doi: 10.1186/s12992-020-00574-3
Commission., C. N. H. (accessed 2020 Apr 12). Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (7thed). fromhttp://kjfy.meetingchina.org/msite/news/show/cn/3337.html
Coondoo, A., Phiske, M., Verma, S., & Lahiri, K. (2014). Side-effects of topical steroids: A long overdue revisit. Indian dermatology online journal, 5 (4), 416-425. doi: 10.4103/2229-5178.142483
Costanzo, M., De Giglio, M. A. R., & Roviello, G. N. (2020). SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus. LID - 10.2174/0929867327666200416131117 [doi]. (1875-533X (Electronic)).
Cui, J. A.-O., Li, F., & Shi, Z. A.-O. X. Origin and evolution of pathogenic coronaviruses. (1740-1534 (Electronic)).
Cullen, W., Gulati, G., & Kelly, B. D. (2020). Mental health in the COVID-19 pandemic. QJM, 113 (5), 311-312. doi: 10.1093/qjmed/hcaa110
de Wit, E., Feldmann, F., Cronin, J., Jordan, R., Okumura, A., Thomas, T., . . . Feldmann, H. (2020). Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci U S A, 117 (12), 6771-6776. doi: 10.1073/pnas.1922083117
Deng, S. Q., & Peng, H. A.-O. (2020). Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China. LID - 10.3390/jcm9020575 [doi] LID - 575. (2077-0383 (Print)).
Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., . . . Yang, X. (2020). Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A, 117 (17), 9490-9496. doi: 10.1073/pnas.2004168117
Eisenberg, J. (2020). R0: How Scientists Quantify the Intensity of an Outbreak Like Coronavirus and Its Pandemic Potential.
Elfiky, A. A. (2020). Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci, 248 , 117477. doi: 10.1016/j.lfs.2020.117477
Epidemiology Working Group for Ncip Epidemic Response, C. C. f. D. C., & Prevention. (2020). [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi, 41 (2), 145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003
Esposito, S., Noviello, S., & Pagliano, P. (2020). Update on treatment of COVID-19: ongoing studies between promising and disappointing results. (1124-9390 (Print)).
Evans, A. S. (2013). Viral infections of humans: epidemiology and control : Springer Science & Business Media.
Ferner, R. E., & Aronson, J. K. (2020). Chloroquine and hydroxychloroquine in covid-19. Bmj, 369 (1756-1833 (Electronic)), m1432. doi: 10.1136/bmj.m1432
Gamage, B., Moore, D., Copes, R., Yassi, A., Bryce, E., & Group, B. C. I. R. P. S. (2005). Protecting health care workers from SARS and other respiratory pathogens: a review of the infection control literature. Am J Infect Control, 33 (2), 114-121. doi: 10.1016/j.ajic.2004.12.002
Gorbalenya, A. E. (2020). Severe acute respiratory syndrome-related coronavirus–The species and its viruses, a statement of the Coronavirus Study Group. BioRxiv .
Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., . . . Flanigan, T. (2020). Compassionate Use of Remdesivir for Patients with Severe Covid-19. LID - 10.1056/NEJMoa2007016 [doi] LID - NEJMoa2007016. (1533-4406 (Electronic)).
Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., . . . China Medical Treatment Expert Group for, C. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med, 382 (18), 1708-1720. doi: 10.1056/NEJMoa2002032
Health., D.-G. f. (2020). COVID-19: mitigation phase. Approach of the patient with suspicion or infection with SARS-CoV-2., from https://www.dgs.pt/directrizes-da-dgs/normas-e-circulares-normativas/norma-n-0042020-de-23032020-pdf
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., . . . Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395 (10223), 497-506. doi: 10.1016/S0140-6736(20)30183-5
Huang, J. Z., Han, M. F., Luo, T. D., Ren, A. K., & Zhou, X. P. (2020). [Mental health survey of medical staff in a tertiary infectious disease hospital for COVID-19].Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, 38 (3), 192-195. doi: 10.3760/cma.j.cn121094-20200219-00063
Imai, K., Tabata, S., Ikeda, M., Noguchi, S., Kitagawa, Y., Matuoka, M., . . . Maeda, T. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19. (1873-5967 (Electronic)).
Jakhar, D. A.-O., & Kaur, I. (2020). Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus. (1546-170X (Electronic)).
Jie, C., Fang, L., & Zheng-Li, S. (2019). Origin and evolution of pathogenic coronaviruses. Nature reviews. Microbiology, 17 (3).
Jin, Y. H., Cai, L., Cheng, Z. S., Cheng, H., Deng, T., Fan, Y. P., . . . Health, C. (2020). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res, 7 (1), 4. doi: 10.1186/s40779-020-0233-6
Juurlink, D. N. (2020). Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. Cmaj, 192 (17), E450-E453. doi: 10.1503/cmaj.200528
Kang, S., Peng, W., Zhu, Y., Lu, S., Zhou, M., Lin, W., . . . Deng, M. (2020). Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment. Int J Antimicrob Agents, 55 (5), 105950. doi: 10.1016/j.ijantimicag.2020.105950
Kaplan, S. S., & Hicks, C. B. (2005). Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection. Expert Opin Pharmacother, 6 (9), 1573-1585. doi: 10.1517/14656566.6.9.1573
Keeling, M. J., & Rohani, P. (2011).Modeling infectious diseases in humans and animals : Princeton University Press.
Kim, C. J., Choi, W. S., Jung, Y., Kiem, S., Seol, H. Y., Woo, H. J., . . . Kim, Y. S. (2020). Surveillance of the MERS Coronavirus Infection in Healthcare Workers after Contact with Confirmed MERS Patients: Incidence and Risk Factors of MERS-CoV Seropositivity. Clinical Microbiology & Infection the Official Publication of the European Society of Clinical Microbiology & Infectious Diseases , S1198743X16302415.
Kimberly E. Hanson, A. M. C., Cesar A. Arias. (2020). Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19.
Kisely, S., Warren, N., McMahon, L., Dalais, C., Henry, I., & Siskind, D. (2020). Occurrence, prevention, and management of the psychological effects of emerging virus outbreaks on healthcare workers: rapid review and meta-analysis. Bmj, 369 (1756-1833 (Electronic)), m1642. doi: 10.1136/bmj.m1642
Kristensen, K. E., Torppedersen, C., Gislason, G. H., Egfjord, M., Rasmussen, H. B., & Hansen, P. R. (2015). Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Abdominal Aortic AneurysmsSignificance.Arterioscler Thromb Vasc Biol, 35 (3), 733-740.
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., . . . Deng, W. (2020). A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury.11 (8), 875-879.
Lee, B. Y. (2020). Study: 17.9% Of People With COVID-19 Coronavirus Had No Symptoms.
Lentini, G. A.-O., Cavalluzzi, M. M., & Habtemariam, S. A.-O. (2020). COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help. LID - E1834 [pii] LID - 10.3390/molecules25081834 [doi]. (1420-3049 (Electronic)).
Li-Li, R., Ye-Ming, W., Zhi-Qiang, W., Zi-Chun, X., Li, G., Teng, X., . . . Jian-Wei, W. (2020). Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chinese medical journal .
Li G Fau - De Clercq, E., & De Clercq, E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). (1474-1784 (Electronic)).
Li G Fau - De Clercq, E., & De Clercq, E. (2020). Therapeutic options for the 2019 novel coronavirus (2019-nCoV). (1474-1784 (Electronic)).
Li, W., Yang, Y., Liu, Z. H., Zhao, Y. J., Zhang, Q., Zhang, L., . . . Xiang, Y. T. (2020). Progression of Mental Health Services during the COVID-19 Outbreak in China. Int J Biol Sci, 16 (10), 1732-1738. doi: 10.7150/ijbs.45120
Li, Z., Yi, Y., Luo, X., Xiong, N., Liu, Y., Li, S., . . . Ye, F. (2020). Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. LID - 10.1002/jmv.25727 [doi]. (1096-9071 (Electronic)).
Linton, N. M., Kobayashi, T., Yang, Y., Hayashi, K., Akhmetzhanov, A. R., Jung, S.-m., . . . Nishiura, H. (2020). Epidemiological characteristics of novel coronavirus infection: A statistical analysis of publicly available case data. medRxiv .
Luigi Angelo, V., Giovanni, S., & Giacomo De, R. (2020). The importance of olfactory and gustatory disorders as early symptoms of coronavirus disease (COVID-19).British Journal of Oral and Maxillofacial Surgery .
Macau., U. o. (2020). UM professional team works with government to provide psychological counselling during epidemic period., from https: //wwwumedumo/news-centre/news-and-events/news-and-press-releases/detail/49950/#news_title (access February 17, 2020). 2020
Malta, M., Rimoin, A. W., & Strathdee, S. A. (2020). The coronavirus 2019-nCoV epidemic: Is hindsight 20/20? (2589-5370 (Electronic)).
Marto, N., & Monteiro, E. C. (2020). Medicines for the Treatment Of COVID-19: Awaiting the Evidence. LID - 10.20344/amp.13908 [doi]. (1646-0758 (Electronic)).
Medicine, N. H. C. S. A. o. T. C. (2020). Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia.
medicine, P. S. o. c. (2020). Recommendations of the Portuguese Society of intensive care and group infection and sepsis on the method of covid-19., from https://www.spci.pt/media/covid-19/COVID_19_R_20200331.pdf.
Natsuko Imai, A. C., Ilaria Dorigatti, Marc Baguelin, Christl A. Donnelly, Steven Riley, Neil M. Ferguson. (2020). Report 3: Transmissibility of 2019-nCoV.
Nurses, T. I. C. o. (2020). ICN calls for data on healthcare worker infection rates and deaths.
P, W. A. C., Xin, L., P, L. S. K., & Y, W. P. C. (2019). Global Epidemiology of Bat Coronaviruses.Viruses, 11 (2).
Peng, X., Xu, X., Li, Y., Cheng, L., Zhou, X., & Ren, B. (2020). Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci, 12 (1), 9. doi: 10.1038/s41368-020-0075-9
Pereira, B. A.-O. (2020). Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review. (1521-6950 (Electronic)).
Pranab, C., Nazia, N., Anup, A., Bhabatosh, D., & Raman, R. G. (2020). The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence. The Indian Journal of Medical Research .
Rempenault, C., Combe, B., Barnetche, T., Gaujoux-Viala, C., Lukas, C., Morel, J., & Hua, C. (2020). Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis. (1468-2060 (Electronic)).
Ren, L. L., Wang, Y. M., Wu, Z. Q., Xiang, Z. C., Guo, L., Xu, T., . . . Wang, J. W. (2020). Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl), 133 (9), 1015-1024. doi: 10.1097/CM9.0000000000000722
Rothan, H. A., & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun, 109 , 102433. doi: 10.1016/j.jaut.2020.102433
Savarino A Fau - Di Trani, L., Di Trani L Fau - Donatelli, I., Donatelli I Fau - Cauda, R., Cauda R Fau - Cassone, A., & Cassone, A. (2020). New insights into the antiviral effects of chloroquine. (1473-3099 (Print)).
Schmid, M. B., & Fontijn, J. (2020). COVID-19 in pregnant women. LID - S1473-3099(20)30175-4 [pii] LID - 10.1016/S1473-3099(20)30175-4 [doi] FAU - Schmid, Manuel B. (1474-4457 (Electronic)).
Shajahan, A., Supekar, N. T., Gleinich, A. S., & Azadi, P. (2020). Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2. LID - cwaa042 [pii] LID - 10.1093/glycob/cwaa042 [doi]. (1460-2423 (Electronic)).
Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., . . . Liu, L. (2020). Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.Jama (1538-3598 (Electronic)). doi: 10.1001/jama.2020.4783
Shen, K., Yang, Y., Wang, T., Zhao, D., Jiang, Y., Jin, R., . . . Lin, L. (2020). Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World Journal of Pediatrics , 1-9.
Shigemura, J., Ursano, R. J., Morganstein, J. C., Kurosawa, M., & Benedek, D. M. (2020). Public responses to the novel 2019 coronavirus (2019-nCoV) in Japan: Mental health consequences and target populations. Psychiatry Clin Neurosci, 74 (4), 281-282. doi: 10.1111/pcn.12988
World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19) , (2020).
Stower, H. (2020). Lopinavir-ritonavir in severe COVID-19. Nat Med, 26 (4), 465. doi: 10.1038/s41591-020-0849-9
Sun, J., He, W. T., Wang, L., Lai, A., Ji, X., Zhai, X., . . . Su, S. (2020). COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives. Trends Mol Med, 26 (5), 483-495. doi: 10.1016/j.molmed.2020.02.008
Sun, P., Lu, X., Xu, C., Sun, W., & Pan, B. (2020). Understanding of COVID‐19 based on current evidence.Journal of medical virology .
Sun, Z., Thilakavathy, K., Kumar, S. S., He, G., & Liu, S. V. (2020). Potential Factors Influencing Repeated SARS Outbreaks in China. Int J Environ Res Public Health, 17 (5), 1633. doi: 10.3390/ijerph17051633
Surveillances, V. (2020). The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)-China, 2020. fromhttp://weekly.chinacdc.cn/en/article/id
Tian, S., Hu, W., Niu, L., Liu, H., Xu, H., & Xiao, S. Y. (2020). Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer.J Thorac Oncol, 15 (5), 700-704. doi: 10.1016/j.jtho.2020.02.010
Tiwari, R., Dhama, K., Sharun, K., Iqbal Yatoo, M., Malik, Y. S., Singh, R., . . . Rodriguez-Morales, A. J. (2020). COVID-19: animals, veterinary and zoonotic links. Vet Q, 40 (1), 169-182. doi: 10.1080/01652176.2020.1766725
Udugama, B., Kadhiresan, P., Kozlowski, H. N., Malekjahani, A., Osborne, M., Li, V. Y. C., . . . Chan, W. C. W. (2020). Diagnosing COVID-19: The Disease and Tools for Detection. ACS Nano, 14 (4), 3822-3835. doi: 10.1021/acsnano.0c02624
van Griensven, J., Edwards T Fau - de Lamballerie, X., de Lamballerie X Fau - Semple, M. G., Semple Mg Fau - Gallian, P., Gallian P Fau - Baize, S., Baize S Fau - Horby, P. W., . . . Haba, N. (2020). Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. (1533-4406 (Electronic)).
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., . . . Xiong, Y. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama .
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., . . . Peng, Z. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama (1538-3598 (Electronic)). doi: 10.1001/jama.2020.1585
Wang, H. J., Du, S. H., Yue, X., & Chen, C. X. (2020). Review and Prospect of Pathological Features of Corona Virus Disease. Fa Yi Xue Za Zhi, 36 (1), 16-20. doi: 10.12116/j.issn.1004-5619.2020.01.004
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., . . . Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res, 30 (3), 269-271. doi: 10.1038/s41422-020-0282-0
Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., . . . Wang, C. (2020). Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet, 395 (10236), 1569-1578. doi: 10.1016/S0140-6736(20)31022-9
Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V., . . . Bavari, S. (2020). Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. (1476-4687 (Electronic)).
WHO. (2020a). Coronavirus disease (COVID-19) Situation Report. from https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200522-covid-19-sitrep-123.pdf?sfvrsn=5ad1bc3_4
WHO. (2020b). WHO launches global megatrial of the four most promising coronavirus treatments. from https://www.sciencemag.org/news/2020/03/who-launches-global-megatrial-four-most-promising-coronavirus-treatments
Wichmann, D., Sperhake, J. P., Lütgehetmann, M., Steurer, S., Edler, C., Heinemann, A., . . . Kluge, S. (2020). Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. LID - 10.7326/M20-2003 [doi]. (1539-3704 (Electronic)).
Wilson KC, C. S., Bai C, Rello J. (2020). COVID-19: Interim guidance on management pending empirical evidence; from an American Thoracic Society led international task force. from https://www.thoracic.org/professionals/clinical-resources/disease-related-resources/covid-19-guidance.pdf
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., . . . Song, Y. (2020). Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. LID - 10.1001/jamainternmed.2020.0994 [doi] LID - e200994. (2168-6114 (Electronic)).
Xiaobo, Y., Yuan, Y., Jiqian, X., Huaqing, S., Jia’an, X., Hong, L., . . . Department of Critical Care Medicine, R. H. o. W. U. W. C. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine, 8 (5).
Xie, M., & Chen, Q. (2020). Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV. (1878-3511 (Electronic)).
Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., . . . Hao, P. (2020). Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci, 63 (3), 457-460. doi: 10.1007/s11427-020-1637-5
Xu, X. W., Wu, X. X., Jiang, X. G., Xu, K. J., Ying, L. J., Ma, C. L., . . . Li, L. J. (2020). Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.Bmj, 368 , m606. doi: 10.1136/bmj.m606
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., . . . Wang, F. S. (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 8 (4), 420-422. doi: 10.1016/S2213-2600(20)30076-X
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., . . . Shang, Y. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med, 8 (5), 475-481. doi: 10.1016/S2213-2600(20)30079-5
Ying, L., A, G. A., Annelies, W.-S., & Joacim, R. (2020). The reproductive number of COVID-19 is higher compared to SARS coronavirus. Journal of travel medicine .
Yu, P. (2020). A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period. (1537-6613 (Electronic)).
Zha, L., Li, S., Pan, L., Tefsen, B., Li, Y., French, N., . . . Villanueva, E. V. (2020). Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19).Med J Aust, 212 (9), 416-420. doi: 10.5694/mja2.50577
Zhang, W., Du, R. H., Li, B., Zheng, X. S., Yang, X. L., Hu, B., . . . Zhou, P. (2020). Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect, 9 (1), 386-389. doi: 10.1080/22221751.2020.1729071
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., . . . Tan, W. (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine .
Zu, Z. Y., Jiang, M. D., Xu, P. P., Chen, W., Ni, Q. Q., Lu, G. M., & Zhang, L. J. (2020). Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology , 200490. doi: 10.1148/radiol.2020200490